A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells

Upon functional loss of insulin producing islet β-cells, some patients with diabetes become dependent on life-long insulin supplementation therapy. Bioengineering surrogate insulin producing cells is an alternative replacement strategy. We have developed a novel approach using short-activating RNA o...

Descripción completa

Detalles Bibliográficos
Autores principales: Reebye, Vikash, Sætrom, Pål, Mintz, Paul J, Rossi, John J, Kasahara, Noriyuki, Nteliopoulos, Georgios, Nicholls, Joanna, Haoudi, Abdelali, Gordon, Myrtle, Habib, Nagy A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696904/
https://www.ncbi.nlm.nih.gov/pubmed/23736775
http://dx.doi.org/10.1038/mtna.2013.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696904/
https://www.ncbi.nlm.nih.gov/pubmed/23736775
http://dx.doi.org/10.1038/mtna.2013.23

Ejemplares similares